Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.46EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.58 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.21EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.31EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CP.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBGEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.98 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.1.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.4.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.16 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.10.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.4.5 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.34.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.4.2.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.9.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.55EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.39EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XWEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KG.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDJEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.3.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.36.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.86.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LV.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GE.1.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-1935.15South Korea
JN.2.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JC.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KE.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.8.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.56EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JD.1.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDTEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.21EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.2.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.617.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.109 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.4.2.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.4.2.3 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.4.8 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.617.1 (Kappa)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used